Finance

Lists
BHC:NYSE
Bausch Health Companies Inc
၆.၀၅ US$
-၁.၇၁%
(-၀.၁၁) 1D
အောက် ၈, GMT-၄ ၁၅:၃၃:၀၇  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for BHC...
Open
၆.၁၄ US$
High
၆.၂၀ US$
Low
၆.၀၂ US$
Mkt. cap
၂၂၆.၅၇ ဋေ
Avg. vol.
၂.၂၅ သန်း
Volume
၈.၃၄ သိန်း
52-wk high
၈.၀၀ US$
52-wk low
၄.၃၃ US$
EPS
-၂.၉၆ US$
Beta
၀.၃၇
Shares outstanding
၃၇.၄၀ ကုဋေ
No. of employees
၂ သောင်း
Open
၆.၁၄ US$
High
၆.၂၀ US$
Low
၆.၀၂ US$
Mkt. cap
၂၂၆.၅၇ ဋေ
Avg. vol.
၂.၂၅ သန်း
Volume
၈.၃၄ သိန်း
52-wk high
၈.၀၀ US$
52-wk low
၄.၃၃ US$
EPS
-၂.၉၆ US$
Beta
၀.၃၇
Shares outstanding
၃၇.၄၀ ကုဋေ
No. of employees
၂ သောင်း
News stories
From web sources and news partners
Investing.com
Investing.com
·
ပြီးခဲ့သည့် ၉ နာရီ
RBC Capital maintains Bausch Health stock rating ahead of Q3 results
Yahoo Finance
Yahoo Finance
·
ပြီးခဲ့သည့် ၂ ရက်
Bausch Health to Announce Third Quarter 2026 Results on October 28, 2026
Yahoo! Finance Canada
Yahoo! Finance Canada
·
ပြီးခဲ့သည့် ၃ ရက်
Stocks in play: Bausch + Lomb Corporation
Profile
Bausch Health Companies Inc. is a global, diversified Canadian pharmaceutical company. Its global corporate headquarters are located in Laval, Quebec, Canada, and its U.S. headquarters are in Bridgewater, New Jersey. It develops, manufactures and markets a range of pharmaceutical products in gastroenterology, hepatology, neuroscience, dermatology, dentistry, medical aesthetics, and international pharmaceuticals. Bausch Health manufactures and markets branded pharmaceuticals, generic pharmaceuticals, and over-the-counter products directly or indirectly in more than 90 countries and regions, including the United States, Canada, Europe, the Middle East, Africa, Asia Pacific and Latin America. Wikipedia
About Bausch Health Companies Inc
CEOThomas J. Appio
Employees၂.၀၃ သောင်း
Founded၁၉၅၉
Headquartersလာဗဲလ်, ကွီဗက်ပြည်နယ်, ကနေဒါ
Sector-
Analyst ratings
Based on 1 analyst giving stock ratings to BHC in the past 3 months
Hold
Buy
0
Hold
1
Sell
0
12-month forecast
Based on 1 Wall Street analyst offering 12-month price targets for BHC in the last 3 months
Highest
Current ၆.၀၅ US$
၉.၀၀ US$ (+၄၈.၇၆%)
Average
၉.၀၀ US$ (+၄၈.၇၆%)
Lowest
၉.၀၀ US$ (+၄၈.၇၆%)
Analyst
Recommendation
Action
Price target
Projected
Date
Douglas Miehm
RBC Capital
Hold
Maintained
၉.၀၀ US$
+၄၈.၈%
10/08/2026
Glen Santangelo
Barclays
Hold
Reiterated
၇.၀၀ US$
+၁၅.၇%
06/03/2026
Les Sulewski
Truist Financial
Hold
Reiterated
-
-
05/01/2026
Michael Nedelcovych
TD Cowen
Hold
Maintained
၇.၀၀ US$
+၁၅.၇%
04/30/2026
Umer Raffat
Evercore ISI
Hold
Maintained
-
-
04/30/2026
Jason Gerberry
Bank of America Securities
Sell
Reiterated
၅.၀၀ US$
-၁၇.၄%
02/18/2026
Last report
၂၀၂၆ ဇူ ၂၉
Fiscal period
Q2 2026
EPS / Est. (USD)
၁.၂၆ US$ / ၁.၀၁ US$
+၂၅.၁၂%beat
Revenue / Est. (USD)
၂၈၅.၂၀ ဋေ / ၂၆၅.၉၁ ဋေ
+၇.၂၅%beat
Fiscal Q2 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
၂၀၂၅ စက်
၂၀၂၅ ဒီ
၂၀၂၆ မတ်
၂၀၂၆ ဇွန်
Revenue
၂၆၈.၁၀ ဋေ
၂၇၉.၆၀ ဋေ
၂၅၂.၄၀ ဋေ
၂၈၅.၂၀ ဋေ
Cost of goods sold
၇၅.၀၀ ကုဋေ
၇၉.၈၀ ကုဋေ
၇၃.၈၀ ကုဋေ
၇၇.၂၀ ကုဋေ
Cost of revenue
၇၅.၀၀ ကုဋေ
၇၉.၈၀ ကုဋေ
၇၃.၈၀ ကုဋေ
၇၇.၂၀ ကုဋေ
Research and development expenses
၁၆.၆၀ ကုဋေ
၁၆.၁၀ ကုဋေ
၁၆.၃၀ ကုဋေ
၁၇.၃၀ ကုဋေ
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
၇၉.၅၀ ကုဋေ
၈၈.၀၀ ကုဋေ
၈၆.၀၀ ကုဋေ
၉၀.၇၀ ကုဋေ
Operating expense
၁၂၁.၄၀ ဋေ
၁၂၇.၇၀ ဋေ
၁၂၆.၅၀ ဋေ
၁၃၀.၅၀ ဋေ
Total operating expenses
၁၉၆.၄၀ ဋေ
၂၀၇.၅၀ ဋေ
၂၀၀.၃၀ ဋေ
၂၀၇.၇၀ ဋေ
Operating income
၇၁.၇၀ ကုဋေ
၇၂.၁၀ ကုဋေ
၅၂.၁၀ ကုဋေ
၇၇.၅၀ ကုဋေ
Other non operating income
-
-
-
-
EBT including unusual items
၂၁.၈၀ ကုဋေ
၅.၆၀ ကုဋေ
-၁၃၅.၄၀ ဋေ
၃၄.၈၀ ကုဋေ
EBT excluding unusual items
၃၁.၃၀ ကုဋေ
၃၂.၂၀ ကုဋေ
၁၁.၈၀ ကုဋေ
၃၈.၃၀ ကုဋေ
Income tax expense
၃.၇၀ ကုဋေ
၁၅.၉၀ ကုဋေ
၇.၇၀ ကုဋေ
၈.၈၀ ကုဋေ
Effective tax rate
၁၆.၉၇%
၂၈၃.၉၃%
-၅.၆၉%
၂၅.၂၉%
Other operating expenses
-
-
၁.၀၀ သန်း
-
Net income
၁၇.၉၀ ကုဋေ
-၁၁.၂၀ ကုဋေ
-၁၄၂.၃၀ ဋေ
၂၅.၈၀ ကုဋေ
Net profit margin
၆.၆၈%
-၄.၀၁%
-၅၆.၃၈%
၉.၀၅%
Earnings per share
၁.၁၆
၁.၁၀
၀.၇၈
၁.၂၆
Interest and investment income
၁.၅၀ ကုဋေ
၉.၀၀ သန်း
၁.၀၀ ကုဋေ
၁.၁၀ ကုဋေ
Interest expense
-၄၁.၂၀ ကုဋေ
-၃၉.၇၀ ကုဋေ
-၄၀.၂၀ ကုဋေ
-၃၉.၆၀ ကုဋေ
Net interest expenses
-၃၉.၇၀ ကုဋေ
-၃၈.၈၀ ကုဋေ
-၃၉.၂၀ ကုဋေ
-၃၈.၅၀ ကုဋေ
Depreciation and amortization charges
-
-
-
-
EBITDA
၁၀၂.၃၀ ဋေ
၁၀၁.၁၀ ဋေ
၈၁.၆၀ ကုဋေ
၁၀၅.၆၀ ဋေ
Gain or loss from assets sale
-၆.၀၀ သန်း
-
-၃.၀၀ သန်း
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
Google အက်ပ်များ